← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sapere Bio, Inc.
Durham, NC
$4,121,162
Total funding
4
Grants
Funding over time
peak $1.6M · FY2014–23$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,121,162 · 4
By mechanism
R44$3,699,879 · 2
R43$421,283 · 2
Investigators at Sapere Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Measuring cellular senescence to predict and prevent peripheral neuropathy$914,673
R44 · FY2021 · AG
Measuring cellular senescence to predict and prevent peripheral neuropathy$903,506
R44 · FY2022 · AG
AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery$893,202
R44 · FY2020 · AG
AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery$661,293
R44 · FY2021 · AG
Development of biomarker of aging as predictor of AKI due to cardiac surgery$224,576
R43 · FY2015 · AG
AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery$216,465
R44 · FY2018 · AG
A biomarker of aging as a predictor of kidney transplant function$121,635
R43 · FY2014 · AG
Measuring cellular senescence to predict and prevent peripheral neuropathy$110,740
R44 · FY2023 · AG
Development of biomarker of aging as predictor of AKI due to cardiac surgery$75,072
R43 · FY2016 · AG